Abstract 1340: Temporal Evolution of Mechanical Thrombectomy: Technology, Patient Selection, And Outcomes, 2012-2024
Stroke: Vascular and Interventional Neurology · 18.10.2026 · 6 (Suppl_1)
DOI: 10.1161/svi270000_1340 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stroke: Vascular and Interventional Neurology, erschienen am 18.10.2026. Verfasst von A. Gupta und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Mechanical thrombectomy has evolved rapidly alongside expanding treatment eligibility and changing referral patterns. We evaluated temporal changes in thrombectomy technology, patient selection, procedural performance, and clinical outcomes, and examined whether worsening contemporary outcomes persisted after adjustment for measured differences in treatment context and baseline characteristics.
Methods
We performed a retrospective cohort study of 1,100 patients treated with mechanical thrombectomy from 2012-2024. Temporal trends in device adoption, treatment timing, procedural performance, and outcomes were evaluated across three eras: 2012-2014, 2015-2019, and 2020-2024. Multivariable logistic regression evaluated the association of contemporary treatment era with good 90-day outcome (modified Rankin Scale [mRS] 0-2) and mortality. Because 81.7% of 90-day mRS values were missing in 2021, the primary 90-day analysis compared 2012-2019 with 2022-2024. Models adjusted for age, admission NIHSS, occlusion anatomy, transfer status, wake-up presentation, and LKW-to-puncture time, with sensitivity analyses incorporating intubation, diabetes, prior stroke/TIA, ASPECTS, and Hispanic ethnicity.
Results
Aspiration use increased from 34.6% to 91.4%, and super-large-bore aspiration from 0% to 16.4%. Median puncture-to-recanalization time decreased from 50.5 to 25 minutes, while first-pass effect increased from 36.8% to 46.5% and successful reperfusion from 88.9% to 92.6%. In parallel, treatment >12 hours from last known well increased from 19.2% to 33.5%, intubation from 33.1% to 46.2%, and transfer-in from 26.7% to 44.2%. Median admission NIHSS remained similar (17 vs 16). Good 90-day outcome declined from 46.4% to 19.7%, with median 90-day mRS increasing from 3 to 5. After adjustment, 2022-2024 was associated with lower odds of good 90-day outcome (OR 0.24, 95% CI 0.15-0.38). This association remained stable after adjustment for LKW-to-puncture, intubation, diabetes/prior stroke/TIA, ASPECTS (OR 0.29, 95% CI 0.15-0.51), and Hispanic ethnicity (OR 0.25, 95% CI 0.15-0.41). Mortality was higher in the contemporary period, while its adjusted association attenuated from OR 1.59 (95% CI 1.03-2.44) to OR 1.41 (95% CI 0.87-2.27) with expanded adjustment.
Conclusion
Over 12 years, thrombectomy became substantially faster and technically more effective while the treated population became broader and more heterogeneous, with greater use of late-window treatment and intubation. Despite procedural improvements, contemporary patients had markedly worse observed functional outcomes, and the association persisted across multiple sensitivity analyses. These findings support an interpretation centered on changing patient selection, referral patterns, treatment windows, and residual unmeasured factors, including unavailable pre-stroke mRS, rather than an adverse effect of newer thrombectomy technology.
Zitieren
APA
Gupta, A., Tekle, W. G., Bakhsh, A., & Hassan, A. E. (2026). Abstract 1340: Temporal Evolution of Mechanical Thrombectomy: Technology, Patient Selection, And Outcomes, 2012-2024. Stroke: Vascular and Interventional Neurology, 6(Suppl_1). https://doi.org/10.1161/svi270000_1340
Vancouver
Gupta A, Tekle WG, Bakhsh A, Hassan AE. Abstract 1340: Temporal Evolution of Mechanical Thrombectomy: Technology, Patient Selection, And Outcomes, 2012-2024. Stroke: Vascular and Interventional Neurology. 2026;6(Suppl_1). doi:10.1161/svi270000_1340
BibTeX
@article{Gupta2026,
author = {Gupta, A. and Tekle, W. G. and Bakhsh, A. and Hassan, A. E.},
title = {Abstract 1340: Temporal Evolution of Mechanical Thrombectomy: Technology, Patient Selection, And Outcomes, 2012-2024},
journal = {Stroke: Vascular and Interventional Neurology},
year = {2026},
volume = {6},
number = {Suppl_1},
doi = {10.1161/svi270000_1340}
}
EUVIMED